ATE536178T1 - Therapeutische anwendung von methionin zur behandlung oder prävention von mucositis - Google Patents
Therapeutische anwendung von methionin zur behandlung oder prävention von mucositisInfo
- Publication number
- ATE536178T1 ATE536178T1 AT04810055T AT04810055T ATE536178T1 AT E536178 T1 ATE536178 T1 AT E536178T1 AT 04810055 T AT04810055 T AT 04810055T AT 04810055 T AT04810055 T AT 04810055T AT E536178 T1 ATE536178 T1 AT E536178T1
- Authority
- AT
- Austria
- Prior art keywords
- methionine
- mucositis
- treatment
- prevention
- therapeutic use
- Prior art date
Links
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 title abstract 2
- 206010028116 Mucosal inflammation Diseases 0.000 title abstract 2
- 201000010927 Mucositis Diseases 0.000 title abstract 2
- 229930182817 methionine Natural products 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 abstract 4
- 230000000259 anti-tumor effect Effects 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052697 platinum Inorganic materials 0.000 abstract 2
- 206010073306 Exposure to radiation Diseases 0.000 abstract 1
- 239000003223 protective agent Substances 0.000 abstract 1
- 230000005855 radiation Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/694,436 US20050090551A1 (en) | 2003-10-27 | 2003-10-27 | Therapeutic use of methionine for the treatment or prevention of mucositis |
| PCT/US2004/035626 WO2005039554A2 (en) | 2003-10-27 | 2004-10-27 | Therapeutic use of methionine for the treatment or prevention of mucositis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE536178T1 true ATE536178T1 (de) | 2011-12-15 |
Family
ID=34522601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04810055T ATE536178T1 (de) | 2003-10-27 | 2004-10-27 | Therapeutische anwendung von methionin zur behandlung oder prävention von mucositis |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20050090551A1 (de) |
| EP (1) | EP1677775B1 (de) |
| JP (1) | JP4884974B2 (de) |
| AT (1) | ATE536178T1 (de) |
| AU (1) | AU2004283756B2 (de) |
| CA (1) | CA2543870C (de) |
| ES (1) | ES2376102T3 (de) |
| WO (1) | WO2005039554A2 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7071230B2 (en) * | 1997-10-02 | 2006-07-04 | Board Of Trustees Of Southern Illinois University | Therapeutic use of D-methionine to reduce the toxicity of noise |
| US20070231377A1 (en) * | 2006-03-28 | 2007-10-04 | Novus International Inc. | Compositions for promoting hair growth |
| GB0704718D0 (en) * | 2007-03-12 | 2007-04-18 | Prendergast Patrick T | Compounds and methods for preventing and treating mucositis |
| NZ621196A (en) * | 2008-01-22 | 2015-08-28 | Araim Pharmaceuticals Inc | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage |
| CA2716576A1 (en) | 2008-03-07 | 2009-09-11 | Nageswara R. Palepu | Fulvestrant formulations |
| ES2677618T3 (es) * | 2009-09-14 | 2018-08-03 | Shiseido Company, Ltd. | Composición para mitigar daños inducidos por radiación ultravioleta |
| TW201110995A (en) * | 2009-09-30 | 2011-04-01 | Shiseido Co Ltd | Oral composition for alleviation of ultraviolet radiation-induced damage |
| US8476310B2 (en) | 2009-10-19 | 2013-07-02 | Scidose Llc | Docetaxel formulations with lipoic acid |
| US8541465B2 (en) | 2009-10-19 | 2013-09-24 | Scidose, Llc | Docetaxel formulations with lipoic acid and/or dihydrolipoic acid |
| US8912228B2 (en) | 2009-10-19 | 2014-12-16 | Scidose Llc | Docetaxel formulations with lipoic acid |
| US7772274B1 (en) | 2009-10-19 | 2010-08-10 | Scidose, Llc | Docetaxel formulations with lipoic acid |
| JP5578997B2 (ja) * | 2010-09-16 | 2014-08-27 | 国立大学法人 大分大学 | がん化学療法誘発脱毛に対する抗脱毛用組成物 |
| US11179468B2 (en) | 2012-04-09 | 2021-11-23 | Eagle Pharmaceuticals, Inc. | Fulvestrant formulations |
| WO2020036975A1 (en) | 2018-08-14 | 2020-02-20 | Tosk, Inc. | Methods and compositions for reducing fluorouracil induced toxicity |
| US11446303B2 (en) | 2019-06-21 | 2022-09-20 | Tosk, Inc. | Uridine phosphorylase (UPase) inhibitors for treatment of liver conditions |
| EP4178581A4 (de) | 2020-07-07 | 2024-06-05 | Tosk, Inc. | Uridinphosphorylasehemmer zur behandlung oder prävention von lungenerkrankungen |
| CN114051974B (zh) * | 2021-11-10 | 2023-01-17 | 广西医科大学 | 一种肝癌模型及其构建方法与应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3652290A (en) * | 1970-08-10 | 1972-03-28 | Merck & Co Inc | Beverages containing stabilized vitamin c |
| US3962429A (en) * | 1973-08-01 | 1976-06-08 | Chugai Seiyaku Kabushiki Kaisha | Method for reducing side effects of aminoglycoside antibiotics and composition therefor |
| US4961926A (en) * | 1987-11-19 | 1990-10-09 | Sloan-Kettering Institute For Cancer Research | Methods for prevention and treatment of mucositis with granulocyte colony stimulating factor |
| US5122369A (en) * | 1990-03-30 | 1992-06-16 | Harmony Health Products, Inc. | Nutrient composition for preventing hair loss |
| EP0768866B1 (de) * | 1994-07-01 | 2002-04-10 | The Procter & Gamble Company | Abschuppungs-zusammensetzung |
| JPH08190187A (ja) * | 1995-01-11 | 1996-07-23 | Canon Inc | 情報記録装置 |
| US5667791A (en) * | 1996-05-31 | 1997-09-16 | Thione International, Inc. | X-ray induced skin damage protective composition |
| ES2263172T3 (es) * | 1996-10-03 | 2006-12-01 | Southern Illinois University | D-metionina para reducir la toxicidad de los compuestos antitumorales que contienen platino. |
| US6187817B1 (en) * | 1996-10-03 | 2001-02-13 | Southern Illinois University School Of Medicine | Therapeutic use of d-methionine to reduce the toxicity of platinum-containing anti-tumor compounds |
| ES2302373T3 (es) * | 1998-02-13 | 2008-07-01 | Nutramax Laboratories, Inc. | Agentes y metodos para la proteccion, tratamiento y reparacion de tejidos conectivos. |
| EP1194161B1 (de) * | 1999-07-13 | 2005-11-23 | Biovitrum Ab | Zusammensetzungen mit stabilem faktor viii |
| EP1381397B1 (de) * | 2000-10-24 | 2007-02-28 | CIS bio international | Stabilisierung von radiopharmazeutischen zusammensetzungen mit einem hydrophilen thioether oder einem hydrophilen 6-hydroxy-chroman |
| WO2002041837A2 (en) * | 2000-11-22 | 2002-05-30 | Rxkinetix, Inc. | Treatment of mucositis |
| MXPA03007802A (es) * | 2001-03-09 | 2003-12-08 | Nestle Sa | Composicion que mejora las deficiencias fisiologicas relacionadas con la edad y que incrementa la longevidad. |
| JP2005510537A (ja) * | 2001-11-29 | 2005-04-21 | サウンド・ファーマシューティカルズ・インコーポレイテッド | 化学療法の所望されない効果を改善する方法および組成物 |
| US20040198841A1 (en) * | 2003-03-13 | 2004-10-07 | Oregon Health & Science University | Use of thiol-based compositions in ameliorating mucosal injury |
| JP2008513455A (ja) * | 2004-09-14 | 2008-05-01 | モレキュラー セラピューティクス インコーポレーティッド | 改良された生物薬剤学的性質をもつｄ−メチオニン製剤 |
-
2003
- 2003-10-27 US US10/694,436 patent/US20050090551A1/en not_active Abandoned
-
2004
- 2004-10-27 AU AU2004283756A patent/AU2004283756B2/en not_active Ceased
- 2004-10-27 EP EP04810055A patent/EP1677775B1/de not_active Expired - Lifetime
- 2004-10-27 CA CA2543870A patent/CA2543870C/en not_active Expired - Fee Related
- 2004-10-27 ES ES04810055T patent/ES2376102T3/es not_active Expired - Lifetime
- 2004-10-27 WO PCT/US2004/035626 patent/WO2005039554A2/en not_active Ceased
- 2004-10-27 AT AT04810055T patent/ATE536178T1/de active
- 2004-10-27 JP JP2006538213A patent/JP4884974B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004283756A1 (en) | 2005-05-06 |
| CA2543870C (en) | 2013-03-12 |
| JP4884974B2 (ja) | 2012-02-29 |
| EP1677775A2 (de) | 2006-07-12 |
| ES2376102T3 (es) | 2012-03-09 |
| JP2007509955A (ja) | 2007-04-19 |
| EP1677775B1 (de) | 2011-12-07 |
| CA2543870A1 (en) | 2005-05-06 |
| US20050090551A1 (en) | 2005-04-28 |
| WO2005039554A2 (en) | 2005-05-06 |
| AU2004283756A2 (en) | 2005-05-06 |
| AU2004283756B2 (en) | 2010-07-29 |
| WO2005039554A3 (en) | 2005-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE536178T1 (de) | Therapeutische anwendung von methionin zur behandlung oder prävention von mucositis | |
| EA200900272A1 (ru) | Комбинации для лечения заболеваний, связанных с клеточной пролиферацией, миграцией или апоптозом клеток миеломы или с ангиогенезом | |
| ATE302003T1 (de) | Zubereitungen enthaltend apomorphin und sildenafil und ihre verwendung zur behandlung von erektiler dysfunktion | |
| NO20061325L (no) | Kombinasjon av legemidler for behandling av neoplasmer | |
| ATE399553T1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
| NO20000688L (no) | Anvendelse av lokalt avleverte metallioner for behandling av periodontal sykdom | |
| BR0212078A (pt) | Método de tratar ou prevenir uma doença relacionada com amilóide em um paciente, composição farmacêutica, composto quìmico, e, uso de um composto | |
| CY1108629T1 (el) | Συνδυασμος ετ 743 με 5 φθοριοουρακιλο προ-φαρμακα δια την θεραπευτικη αγωγη του καρκικου | |
| ECSP055970A (es) | Uso de palonosetron para el tratamiento de nausea y vomito post operatorio | |
| ATE412646T1 (de) | Zur behandlung von schmerzen geeignete therapeutische mittel | |
| EE200200565A (et) | Vaskulaarse kahjustava toimega kombinatsioonravi | |
| WO2022271810A3 (en) | Bicyclic peptidyl pan-ras inhibitors | |
| WO2004039325A3 (en) | Treatment of pain with jnk inhibitors | |
| EA200600921A1 (ru) | Способы и композиции с применением талидомида для лечения и менеджмента рака и других заболеваний | |
| NO20064287L (no) | Dalbavancin-materialer for behandling av bakterielle infeksjoner | |
| DE69400353D1 (de) | Schlankmachende Zusammensetzung | |
| BR0310061A (pt) | Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições | |
| DE602004024221D1 (de) | Behandlung von entzündlichen darmerkrankungen mit 2-methylen-19-nor-vitamin d verbindungen | |
| BRPI0409699A (pt) | métodos de indução do efeito diurético, de indução, manutenção ou restauração do efeito diurético de diurético não modificador de adenosina, de manutenção, restauração ou melhoria da função renal em paciente, de indução de diurese, de prevenção do inìcio de deficiência renal em paciente com sobrecarga de fluidos ou chf, de tratamento de paciente que sofre de chf e de melhoria dos resultados globais da saúde, composição farmacêutica e seus usos | |
| ATE374605T1 (de) | Transdermale verabreichung von (r)-3,3- diphenylpropylamin-monoestern | |
| CA2516458A1 (en) | Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis | |
| EA200600989A1 (ru) | Применение габоксадола для лечения бессонницы | |
| BR0317772A (pt) | Método de tratamento de um distúrbio de comportamento, uso de um composto, e, agente terapêutico para um distúrbio de comportamento | |
| BR0315374A (pt) | Compostos orgânicos | |
| ATE458477T1 (de) | Pharmazeutische zusammensetzung enthaltend in assoziation ubidecarenon, dexpanthenol und chlorhexidine oder eines seiner pharmazeutischen unbedenklichen salze zur anwendung auf der haut |